Qualifying Event Proximity, Cardiovascular Risk, and...

Heart, Lung and Circulation 2019 Vol. 28

Qualifying Event Proximity, Cardiovascular Risk, and Benefit of Empagliflozin in Patients with Type 2 Diabetes and Stable Atherosclerosis in the EMPA-REG OUTCOME Trial

D’Emden, M., Udell, J., Zinman, B., Wanner, C., von Eynatten, M., George, J., Zwiener, I., Lund, S., Hantel, S., Fitchett, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Year:
2019
Language:
english
Journal:
Heart, Lung and Circulation
DOI:
10.1016/j.hlc.2019.06.417
File:
PDF, 184 KB
english, 2019
Conversion to is in progress
Conversion to is failed